NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will collaborate with Expression Pathology in applying their respective proteomic and microdissection technologies to measure cancer-related proteins in formalin-fixed paraffin-embedded tissue.

The collaboration will involve using Thermo Fisher's mass spectrometry technologies with Expression Pathology's laser microdissection and Liquid Tissue sample processing tools to study these proteins using an alternative to immunohistochemistry (IHC) and tissue morphology techniques.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.